TrialPloS one2022

An efficacy and safety report based on randomized controlled single-blinded multi-centre clinical trial of ZingiVir-H, a novel herbo-mineral formulation designed as an add-on therapy in adult patients with mild to moderate COVID-19.

Shan Sasidharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.